BioSpace News Archive

Business

Doug Kohrs appointed to Sequana Medical Board of Directors

Sequana Medical NV, a pioneer in the treatment of drug-resistant fluid overload in liver disease and heart failure, announces the appointment of Doug Kohrs as an independent Non-Executive Director of the Company.

July 19, 2022
·
5 min read
Drug Development

Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update

Sequana Medical NV announces the completion of enrollment in its Phase 2a SAHARA proof-of-concept study using its first-generation DSR product as treatment for congestive heart failure.

July 19, 2022
·
12 min read
Biotech Beach

A Game-Changer for Young Children with Femur Fractures

For decades, the treatment for a young child with a broken femur has been the same: a surgically placed spica cast, commonly known as a body cast.

July 19, 2022
·
5 min read
Drug Development

SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that a phase III clinical trial for SINOVAC’s inactivated quadrivalent influenza vaccine was initiated in the Republic of Chile through a collaboration with the Pontificia Universidad Católica de Chile.

July 19, 2022
·
2 min read
Business

Hansa Biopharma half year report 2022

Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, announced its business update and interim report for January to June 2022.

July 19, 2022
·
9 min read
Business

Mainz Biomed Appoints Dr. Timothy Wang to Newly Formed Medical Advisory Board

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced the formation of a Medical Advisory Board, and the appointment of Dr. Timothy Wang as its inaugural member.

July 19, 2022
·
8 min read
Paragraf® Announces Innovate UK Biomedical Catalyst Grant Award to Develop the First Proof of Concept Graphene-based Diagnostic Test to Immediately Identify Patients Who Need an Antibiotic Treatment

Paragraf, the first company in the world to deliver a scalable approach to graphene electronic device manufacturing, announces a plan to develop a new generation of graphene-based, in-vitro diagnostic products that will give results within a few minutes.

July 19, 2022
·
10 min read
Genetown

CN Bio Opens New Laboratory Facilities to Extend Organ-on-a-chip Contract Research Services Capabilities

CN Bio, a leading Organ-on-a-chip Company that designs and manufactures single-and multi-organ microphysiological systems, announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services.

July 19, 2022
·
2 min read
Ribbon Biolabs Establishes IP Portfolio with First Granted U.S. Patent Covering Fast, Cost-Effective, Long DNA Synthesis Technology

Ribbon Biolabs announced that the U.S. Patent and Trademark Office has issued U.S. Patent US 2020283756 A1, covering Ribbon Biolabs’ novel method for synthesizing a double stranded polynucleotide, also known as DNA, using a diverse library of oligonucleotides.

July 19, 2022
·
2 min read
Business

Sobi publishes Q2 2022 report

Swedish Orphan Biovitrum AB announced its report for the second quarter of 2022

July 19, 2022
·
3 min read